Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity

Journal of Neuroscience

Volumn 34, Issue 15, 2014, Pages 5322-5334

  Gong, Nian ^a   Xiao, Qi ^a   Zhu, Bin ^a   Zhang, Chang Yue ^a   Wang, Yan Chao ^a   Fan, Hui ^a   Ma, Ai Niu ^a   Wang, Yong Xiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chronic pain; GLP 1 receptor; Microglia

Indexed keywords

BETA ACTIN; BETA ENDORPHIN; ENKEPHALIN; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; NEURON SPECIFIC NUCLEAR PROTEIN; SMALL INTERFERING RNA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GENE SILENCING; HYPERSENSITIVITY; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; MOTOR PERFORMANCE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIOIMMUNOPRECIPITATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR SENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAROD TEST; TAIL FLICK TEST; UPREGULATION; WESTERN BLOTTING;

CHRONIC PAIN; GLP-1 RECEPTOR; MICROGLIA;

ANIMALS; BETA-ENDORPHIN; CELLS, CULTURED; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HEK293 CELLS; HUMANS; HYPERALGESIA; MICROGLIA; NEURALGIA; NOCICEPTION; PEPTIDE FRAGMENTS; PEPTIDES; POSTERIOR HORN CELLS; RATS; RATS, WISTAR; RECEPTORS, GLUCAGON; VENOMS;

EID: 84899478592     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4703-13.2014     Document Type: Article

References (71)

1. Alvarez E, Martínez MD, Roncero I, Chowen JA, García-Cuartero B, Gispert JD, Sanz C, Vazquez P, Maldonado A, de Caceres J, Desco M, Pozo MA, Blazquez E (2005) The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem. J Neurochem 92:798-806. CrossRef Medline
2. Avila-Martin G, Galan-Arriero I, Gomez-Soriano J, Taylor J (2011) Treatment of rat spinal cord injury with the neurotrophic factor albumin-oleic acid: translational application for paralysis, spasticity and pain. PLoS One 6:e26107. CrossRef Medline
3. Bach FW (1997) Beta-endorphin in the brain: a role in nociception. Acta Anaesthesiol Scand 41:133-140. CrossRef Medline
4. Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132:2131-2157. CrossRef Medline
5. Beinborn M, Worrall CI, McBride EW, Kopin AS (2005) A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness. Regul Pept 130:1-6. CrossRef Medline
6. Bullock BP, Heller RS, Habener JF (1996) Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137:2968-2978. CrossRef Medline
7. Cabou C, Burcelin R (2011) GLP-1, the gut-brain, and brain-periphery axes. Rev Diabet Stud 8:418-431. CrossRef Medline
8. Chen XL, Li XY, Qian SB, Wang YC, Zhang PZ, Zhou XJ, Wang YX (2012) Down-regulation of spinal D-amino acid oxidase expression blocks formalin-induced tonic pain. Biochem Biophys Res Commun 421:501-507. CrossRef Medline
9. Coderre TJ, Vaccarino AL, Melzack R (1990) Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res 535:155-158. CrossRef Medline
10. Coopman K, Huang Y, Johnston N, Bradley SJ, Wilkinson GF, Willars GB (2010) Comparative effects of the endogenous agonist glucagon-like peptide-1 (GLP-1)-(7-36) amide and the small-molecule ago-allosteric agent "compound 2" at the GLP-1 receptor. J Pharmacol Exp Ther 334: 795-808. CrossRef Medline
11. Courteix C, Eschalier A, Lavarenne J (1993) Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 53:81-88. CrossRef Medline
12. Davis JA, Singh S, Sethi S, Roy S, Mittra S, Rayasam G, Bansal V, Sattigeri J, Ray A (2010) Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals. Indian J Pharmacol 42:229-233. CrossRef Medline
13. Dickenson AH, Sullivan AF (1987) Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin. Pain 30:349-360. CrossRef Medline
14. Eng J, Kleinman WA, Singh L, Singh G, Raufman JP (1992) Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom: further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 267:7402-7405. Medline
15. Fichna J, Janecka A, Costentin J, Do Rego JC (2007) The endomorphin system and its evolving neurophysiological role. Pharmacol Rev 59:88-123. CrossRef Medline
16. Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Goke B (1993) Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting β-cells. J Biol Chem 268:19650-19655. Medline
17. Gong N, Ma AN, Zhang LJ, Luo XS, Zhang YH, Xu M, Wang YX (2011a) Site-specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity. Br J Pharmacol 163:399-412. CrossRef Medline
18. Gong N, Gao ZY, Wang YC, Li XY, Huang JL, Hashimoto K, Wang YX (2011b) A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats. J Pharmacol Exp Ther 336:282-293. CrossRef Medline
19. Gong N, Wang YC, Wang HL, Ma AN, Hashimoto K, Wang YX (2012) Interactions of the potent D-amino acid oxidase inhibitor CBIO with morphine in pain and tolerance to analgesia. Neuropharmacology 63: 460-468. CrossRef Medline
20. Gong N, Li XY, Xiao Q, Wang YX (2013) Identification of a novel spinal dorsal horn astroglial D-amino acid oxidase-hydrogen peroxide pathway involved in morphine antinociceptive tolerance. Anesthesiology. Advance online publication. Retrieved Aug. 7, 2013. Medline
21. Gosselin RD, Suter MR, Ji RR, Decosterd I (2010) Glial cells and chronic pain. Neuroscientist 16:519-531. CrossRef Medline
22. Green BD, Irwin N, Gault VA, Bailey CJ, O'Harte FP, Flatt PR (2005) Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice. J Endocrinol 185:307-317. CrossRef Medline
23. Gwak YS, Hulsebosch CE (2009) Remote astrocytic and microglial activation modulates neuronal hyperexcitability and below-level neuropathic pain after spinal injury in rat. Neuroscience 161:895-903. CrossRef Medline
24. Himeno T, Kamiya H, Naruse K, Harada N, Ozaki N, Seino Y, Shibata T, Kondo M, Kato J, Okawa T, Fukami A, Hamada Y, Inagaki N, Seino Y, Drucker DJ, Oiso Y, Nakamura J (2011) Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice. Diabetes 60:2397-2406. CrossRef Medline
25. Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-1439. CrossRef Medline
26. Hong M, Sutak M, Jhamandas K (1993) Inhibition of spinal opioid antinociception by intrathecal -endorphin1-27 in the rat. Br J Pharmacol 108: 1137-1142. CrossRef Medline
27. Honore P, Mantyh PW, Rogers SD, Schwei MJ, Salak-Johnson JL, Luger NM, Sabino MC, Clohisy DR (2000) Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 98:585-598. CrossRef Medline
28. Hua XY, Svensson CI, Matsui T, Fitzsimmons B, Yaksh TL, Webb M (2005) Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia. Eur J Neurosci 22:2431-2440. CrossRef Medline
29. Huang JL, Chen XL, Guo C, Wang YX (2012) Contributions of spinal D-amino acid oxidase to bone cancer pain. Amino Acids 43:1905-1918. CrossRef Medline
30. Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S, Gao Y, Chen J (2012) Microglia/ macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43:3063-3070. CrossRef Medline
31. Jimenez Hamann MC, Tsai EC, Tator CH, Shoichet MS (2003) Novel intrathecal delivery system for treatment of spinal cord injury. Exp Neurol 182:300-309. CrossRef Medline
32. Jin SL, Han VK, Simmons JG, Towle AC, Lauder JM, Lund PK (1988) Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol 271:519-532. CrossRef Medline
33. Kim SH, Chuang J (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355-363. Medline
34. Kreymann B, Ghatei MA, Burnet P, Williams G, Kanse S, Diani AR, Bloom SR (1989) Characterization of glucagon-like peptide-1-(7-36)amide in the hypothalamus. Brain Res 502:325-331. CrossRef Medline
35. Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C (1997) Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 77:257-270. CrossRef Medline
36. Latremoliere A, Woolf CJ (2009) Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 10:895-926. CrossRef Medline
37. Li Y, Chigurupati S, Holloway HW, Mughal M, Tweedie D, Bruestle DA, Mattson MP, Wang Y, Harvey BK, Ray B, Lahiri DK, Greig NH (2012) Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis. PLoS One 7:e32008. CrossRef Medline
38. Lindia JA, McGowan E, Jochnowitz N, Abbadie C (2005) Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J Pain 6:434-438. CrossRef Medline
39. Loh HH, Tseng LF, Wei E, Li CH (1976) Endorphin is a potent analgesic agent. Proc Natl Acad Sci U S A 73:2895-2898. CrossRef Medline
40. Lu JM, Gong N, Wang YC, Wang YX (2012) D-Amino acid oxidasemediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain. Br J Pharmacol 165:1941-1955. CrossRef Medline
41. Luger NM, Sabino MA, Schwei MJ, Mach DB, Pomonis JD, Keyser CP, Rathbun M, Clohisy DR, Honore P, Yaksh TL, Mantyh PW (2002) Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain. Pain 99:397-406. CrossRef Medline
42. Maione S, Siniscalco D, Galderisi U, de Novellis V, Uliano R, Di Bernardo G, Berrino L, Cascino A, Rossi F (2002) Apoptotic genes expression in the lumbar dorsal horn in a model neuropathic pain in rat. Neuroreport 13:101-106. CrossRef Medline
43. Mao-Ying QL, Zhao J, Dong ZQ, Wang J, Yu J, Yan MF, Zhang YQ, Wu GC, Wang YQ (2006) A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Biochem Biophys Res Commun 345:1292-1298. CrossRef Medline
44. McIlwain DL, Hoke VB, Kopchick JJ, Fuller CR, Lund PK (2004) Differential inhibition of postnatal brain, spinal cord and body growth by a growth hormone antagonist. BMC Neurosci 5:6. CrossRef Medline
45. Mei XP, Xu H, Xie C, Ren J, Zhou Y, Zhang H, Xu LX (2011) Post-injury administration of minocycline: an effective treatment for nerve-injury induced neuropathic pain. Neurosci Res 70:305-312. CrossRef Medline
46. Merchenthaler I, Lane M, Shughrue P (1999) Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J Comp Neurol 403:261-280. CrossRef Medline
47. Morgado C, Silva L, Pereira-Terra P, Tavares I (2011) Changes in serotoninergic and noradrenergic descending pain pathways during painful diabetic neuropathy: the preventive action of IGF1. Neurobiol Dis 43:275-284. CrossRef Medline
48. Nakamura Y, Morioka N, Abe H, Zhang FF, Hisaoka-Nakashima K, Liu K, Nishibori M, Nakata Y (2013) Neuropathic pain in rats with a partial sciatic nerve ligation is alleviated by intravenous injection of monoclonal antibody to high mobility group box-1. PLoS One. doi: 10.1371/journal-.pone.0073640. CrossRef Medline
49. Perez-Tilve D, Gonzalez-Matías L, Aulinger BA, Alvarez-Crespo M, Gil-Lozano M, Alvarez E, Andrade-Olivie AM, Tschop MH, D'Alessio DA, Mallo F (2010) Exendin-4 increases blood glucose levels acutely in rats by activation of the sympathetic nervous system. AmJ Physiol Endocrinol Metab 298:E1088-E1096. CrossRef Medline
50. Perry T, Haughey NJ, Mattson MP, Egan JM, Greig NH (2002) Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4. J Pharmacol Exp Ther 302:881-888. CrossRef Medline
51. Perry T, Lahiri DK, Sambamurti K, Chen D, Mattson MP, Egan JM, Greig NH (2003) Glucagon-like peptide-1 decreases endogenous amyloid-β peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron. J Neurosci Res 72:603-612. CrossRef Medline
52. Petraschka M, Li S, Gilbert TL, Westenbroek RE, Bruchas MR, Schreiber S, Lowe J, Low MJ, Pintar JE, Chavkin C (2007) The absence of endogenous -endorphin selectively blocks phosphorylation and desensitization of opioid receptors following partial sciatic nerve ligation. Neuroscience 146:1795-1807. CrossRef Medline
53. Raghavendra V, Tanga F, DeLeo JA (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306:624-630. CrossRef Medline
54. Ramos LS, Zippin JH, Kamenetsky M, Buck J, Levin LR (2008) Glucose and GLP-1 stimulate cAMP production via distinct adenylyl cyclases in INS-1E insulinoma cells. J Gen Physiol 132:329-338. CrossRef Medline
55. Roger B, Papin J, Vacher P, Raoux M, Mulot A, Dubois M, Kerr-Conte J, Voy BH, Pattou F, Charpentier G, Jonas JC, Moustaïd-Moussa N, Lang J (2011) Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells. Diabetologia 54:390-402. CrossRef Medline
56. Rondon LJ, Privat AM, Daulhac L, Davin N, Mazur A, Fialip J, Eschalier A, Courteix C (2010) Magnesium attenuates chronic hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat model of diabetic neuropathic pain. J Physiol 588:4205-4215. CrossRef Medline
57. Sacerdote P, Denis-Donini S, Paglia P, Granucci F, Panerai AE, Ricciardi-Castagnoli P (1993) Cloned microglial cells but not macrophages synthesize -endorphin in response to CRH activation. Glia 9:305-310. CrossRef Medline
58. Saper CB (1996) Any way you cut it: a new journal policy for the use of unbiased counting methods. J Comp Neurol 364:5. CrossRef Medline
59. Scholz J, Broom DC, Youn DH, Mills CD, Kohno T, Suter MR, Moore KA, Decosterd I, Coggeshall RE, Woolf CJ (2005) Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci 25:7317-7323. CrossRef Medline
60. Surcheva SK, Surchev LK, Milev MD, Kasakov LN, Vlaskovska MV (2009) Possible involvement of spinal glial cells and glutamatergic transmission in streptozotocin-induced neuropathic pain in rats. J Biomed Clin Res 2:26-30.
61. Syme CA, Zhang L, Bisello A (2006) Caveolin-1 regulates cellular trafficking and function of the glucagon-like peptide 1 receptor. Mol Endocrinol 20:3400-3411. CrossRef Medline
62. Talbot S, Chahmi E, Dias JP, Couture R (2010) Key role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy. J Neuroinflammation 7:36. CrossRef Medline
63. Teramoto S, Miyamoto N, Yatomi K, Tanaka Y, Oishi H, Arai H, Hattori N, Urabe T (2011) Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia. J Cereb Blood Flow Metab 31:1696-1705. CrossRef Medline
64. Tornehave D, Kristensen P, Rømer J, Knudsen LB, Heller RS (2008) Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J Histochem Cytochem 56:841-851. CrossRef Medline
65. Tseng LF, Henneberry B, Collins KA (1995) The antinociception induced by endorphin administered intrathecally is mediated by the activation of -and -opioid receptors in the rat. Naunyn Schmiedebergs Arch Pharmacol 351:464-468. Medline
66. Vahl TP, Tauchi M, Durler TS, Elfers EE, Fernandes TM, Bitner RD, Ellis KS, Woods SC, Seeley RJ, Herman JP, D'Alessio DA (2007) Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 148:4965-4973. CrossRef Medline
67. Villanueva-Penacarrillo ML, Delgado E, Vicent D, Merida E, Alcantara AI, Valverde I (1995) GLP-1(7-36)amide binding in skeletal muscle membranes from streptozotocin diabetic rats. Endocrine 3:685-687. CrossRef Medline
68. Wang YX, Pang CC (1993) Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase. J Pharmacol Exp Ther 265:263-272. Medline
69. Yanagisawa Y, Furue H, Kawamata T, Uta D, Yamamoto J, Furuse S, Katafuchi T, Imoto K, Iwamoto Y, Yoshimura M (2010) Bone cancer induces a unique central sensitization through synaptic changes in a wide area of the spinal cord. Mol Pain 6:38. CrossRef Medline
70. Yin F, Liu JH, Zheng XX, Guo LX (2010) GLP-1 receptor plays a critical role in geniposide-induced expression of heme oxygenase-1 in PC12 cells. Acta Pharmacol Sin 31:540-545. CrossRef Medline
71. Zhao WJ, Gao ZY, Wei H, Nie HZ, Zhao Q, Zhou XJ, Wang YX (2010) Spinal D-amino acid oxidase contributes to neuropathic pain in rats. J Pharmacol Exp Ther 332:248-254. CrossRef Medline